Literature DB >> 16341033

Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML.

B Falini, B Bigerna, A Pucciarini, E Tiacci, C Mecucci, S W Morris, N Bolli, R Rosati, S Hanissian, Z Ma, Y Sun, E Colombo, D A Arber, R Pacini, R La Starza, B Verducci Galletti, B V Galletti, A Liso, M P Martelli, D Diverio, P-G Pelicci, F Lo Coco, F L Coco, M F Martelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16341033     DOI： 10.1038/sj.leu.2404068

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

1.  A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.

Authors:  Carolien M Woolthuis; André B Mulder; Rikst Nynke Verkaik-Schakel; Stefano Rosati; Arjan Diepstra; Eva van den Berg; Jan Jacob Schuringa; Edo Vellenga; Philip M Kluin; Gerwin Huls
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

2.  A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.

Authors:  Paulo Vidal Campregher; Welbert de Oliveira Pereira; Bianca Lisboa; Renato Puga; Elvira Rodrigues Pereira Velloso Deolinda; Ricardo Helman; Luciana Cavalheiro Marti; João Carlos Campos Guerra; Kalliopi N Manola; Roberta Cardoso Petroni; Alanna Mara Pinheiro Sobreira Bezerra; Fernando Ferreira Costa; Nelson Hamerschlak; Fábio Pires de Souza Santos
Journal:  Haematologica       Date:  2016-04-01       Impact factor: 9.941

3.  Myeloid leukemia factor: a return ticket from human leukemia to fly hematopoiesis.

Authors:  Vanessa Gobert; Marc Haenlin; Lucas Waltzer
Journal:  Transcription       Date:  2012-09-01

4.  Myeloid leukemia factor 1 interfered with Bcl-XL to promote apoptosis and its function was regulated by 14-3-3.

Authors:  Yi Sun; Amina Fu; Wu Xu; Jyh-Rong Chao; Simon Moshiach; Stephan W Morris
Journal:  J Physiol Biochem       Date:  2015-11-12       Impact factor: 4.158

5.  The incidence and clinical significance of nucleophosmin mutations in childhood AML.

Authors:  Patrick Brown; Emily McIntyre; Rachel Rau; Soheil Meshinchi; Norman Lacayo; Gary Dahl; Todd A Alonzo; Myron Chang; Robert J Arceci; Donald Small
Journal:  Blood       Date:  2007-04-17       Impact factor: 22.113

6.  Subtype-specific patterns of molecular mutations in acute myeloid leukemia.

Authors:  D Rose; T Haferlach; S Schnittger; K Perglerová; W Kern; C Haferlach
Journal:  Leukemia       Date:  2016-06-10       Impact factor: 11.528

7.  Subcellular localization of full-length human myeloid leukemia factor 1 (MLF1) is independent of 14-3-3 proteins.

Authors:  Manuela Molzan; Christian Ottmann
Journal:  Cell Mol Biol Lett       Date:  2012-12-27       Impact factor: 5.787

8.  Myelopoiesis and myeloid leukaemogenesis in the zebrafish.

Authors:  A Michael Forrester; Jason N Berman; Elspeth M Payne
Journal:  Adv Hematol       Date:  2012-07-19

9.  NPM and NPM-MLF1 interact with chromatin remodeling complexes and influence their recruitment to specific genes.

Authors:  Anaïs Darracq; Helen Pak; Vincent Bourgoin; Farah Zmiri; Graham Dellaire; El Bachir Affar; Eric Milot
Journal:  PLoS Genet       Date:  2019-11-01       Impact factor: 5.917

10.  Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML.

Authors:  Maria Paola Martelli; Roberta Rossi; Alessandra Venanzi; Manja Meggendorfer; Vincenzo Maria Perriello; Giovanni Martino; Orietta Spinelli; Raffaella Ciurnelli; Emanuela Varasano; Lorenzo Brunetti; Stefano Ascani; Corinne Quadalti; Valeria Cardinali; Federica Mezzasoma; Ilaria Gionfriddo; Francesca Milano; Roberta Pacini; Alessia Tabarrini; Barbara Bigerna; Francesco Albano; Giorgina Specchia; Calogero Vetro; Francesco Di Raimondo; Ombretta Annibali; Giuseppe Avvisati; Alessandro Rambaldi; Franca Falzetti; Enrico Tiacci; Paolo Sportoletti; Torsten Haferlach; Claudia Haferlach; Brunangelo Falini
Journal:  Blood       Date:  2021-12-23       Impact factor: 25.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.